| Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. GJ Cook, S Houston, R Rubens, MN Maisey, I Fogelman Journal of clinical oncology 16 (10), 3375-3379, 1998 | 620 | 1998 |
| Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? F Davnall, CSP Yip, G Ljungqvist, M Selmi, F Ng, B Sanghera, ... Insights into imaging 3 (6), 573-589, 2012 | 596 | 2012 |
| Imaging biomarker roadmap for cancer studies JPB O'Connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ... Nature reviews Clinical oncology 14 (3), 169, 2017 | 503 | 2017 |
| Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation GJR Cook, I Fogelman, MN Maisey Seminars in nuclear medicine 26 (4), 308-314, 1996 | 407 | 1996 |
| The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping A Zwanenburg, M Vallières, MA Abdalah, HJWL Aerts, V Andrearczyk, ... Radiology 295 (2), 328-338, 2020 | 405 | 2020 |
| Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ... Breast Cancer Research 15 (5), 1-37, 2013 | 390 | 2013 |
| Quantifying tumour heterogeneity in 18 F-FDG PET/CT imaging by texture analysis S Chicklore, V Goh, M Siddique, A Roy, PK Marsden, GJR Cook European journal of nuclear medicine and molecular imaging 40 (1), 133-140, 2013 | 390 | 2013 |
| Are pretreatment 18F-FDG PET tumor textural features in non–small cell lung cancer associated with response and survival after chemoradiotherapy? GJR Cook, C Yip, M Siddique, V Goh, S Chicklore, A Roy, P Marsden, ... Journal of nuclear medicine 54 (1), 19-26, 2013 | 353 | 2013 |
| Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate GM Blake, SJ Park-Holohan, GJR Cook, I Fogelman Seminars in nuclear medicine 31 (1), 28-49, 2001 | 290 | 2001 |
| Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging GJR Cook, EA Wegner, I Fogelman Seminars in nuclear medicine 34 (2), 122-133, 2004 | 275 | 2004 |
| Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine GJR Cook, MN Maisey, I Fogelman European journal of nuclear medicine 26 (10), 1363-1378, 1999 | 273 | 1999 |
| Positron emission tomography and bone metastases I Fogelman, G Cook, O Israel, H Van der Wall Seminars in nuclear medicine 35 (2), 135-142, 2005 | 270 | 2005 |
| Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma SC Rankin, H Taylor, GJR Cook, R Mason Clinical radiology 53 (9), 659-665, 1998 | 193 | 1998 |
| Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. S Maurea, C Mainolfi, L Bazzicalupo, MR Panico, C Imparato, B Alfano, ... AJR. American journal of roentgenology 173 (1), 25-29, 1999 | 181 | 1999 |
| The role of positron emission tomography in the management of bone metastases GJR Cook, I Fogelman Cancer: Interdisciplinary International Journal of the American Cancer …, 2000 | 172 | 2000 |
| Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG GJR Cook, S Houston, SF Barrington, I Fogelman Journal of Nuclear Medicine 39 (1), 99-103, 1998 | 155 | 1998 |
| The use of 18 F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI G Kong, C Jackson, DM Koh, V Lewington, B Sharma, G Brown, ... European journal of nuclear medicine and molecular imaging 35 (7), 1323-1329, 2008 | 149 | 2008 |
| Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer C Yip, V Goh, A Davies, J Gossage, R Mitchell-Hay, O Hynes, N Maisey, ... European radiology 24 (5), 998-1005, 2014 | 139 | 2014 |
| Non–Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of 18F-FDG Uptake at PET—Association with Treatment Response and Prognosis GJR Cook, ME O’Brien, M Siddique, S Chicklore, HY Loi, B Sharma, ... Radiology 276 (3), 883-893, 2015 | 130 | 2015 |
| Predicting response to neoadjuvant chemotherapy with PET imaging using convolutional neural networks PP Ypsilantis, M Siddique, HM Sohn, A Davies, G Cook, V Goh, ... PloS one 10 (9), e0137036, 2015 | 119 | 2015 |
